Strategic healthcare M&A rebounded in 2021 from a down year in pandemic-ravaged 2020, with volume up 16% and total deal value rising by 44%, to $440 billion, Bain & Company reports. The year 2021 brought with it a return to pre-pandemic trends across all five sectors: pharmaceuticals, medtech, payers, providers, and healthcare services. What’s different this time, though, is that the cost of acquisitions has become dramatically more expensive in most areas, with deal multiples reaching the highest level in decades. Paying for these inflated multiples requires companies to get more creative in their deal theses and focus on better execution to deliver on deal value. Here’s what the best acquirers are doing. Read more.
Related Posts
Hospital Margins See No Relief to Start the Year
The year is off to an unfriendly start for hospital finances, with a median margin of -1 percent for January, worsening from the margin recorded a month prior, according to Kaufman Hall.
February 28, 2023
Mayo Clinic Thanks Governor, Legislators After Staffing Bill Revamp
However, the Minnesota Nurses Association — which has backed the Keeping Nurses at the Bedside Act from the beginning — is disheartened by the initial bill's demise.
May 25, 2023
M&A Action is About to go Viral in Chicago Hospital Biz
At a time when most hospital systems are looking to bulk up, Amita Health’s split sets the stage for more dealmaking in Chicago's rapidly consolidating healthcare market.
November 1, 2021
Physician Medical Group M&A Activity Surged in Q3
Deal volume in the Physician Medical Groups (PMG) sector climbed in the third quarter of 2022, up 16% with 170 publicly announced transactions, compared with 147 acquisitions in the second quarter of 2022.
October 14, 2022